Diabetes

A diabetes care team that included a clinical pharmacist led to major improvements in glycemic control, LDL cholesterol levels, blood pressure, and long-term cardiovascular risk.

New guidelines from the American Association of Clinical Endocrinologists cover therapy with all approved classes of diabetes drugs as well as obesity, prediabetes, and cardiovascular risk factor management.

An appeals court rules on the case of a patient who received medication meant for someone with a similar name.

Avoiding unnecessary utilization of hospitals, improving quality of care, and establishing continuous chronic disease management.

Acute coronary syndrome patients often have complex medication regimens, which means that pharmacists play an important role in condition management and patient counseling.

More than half of diabetes patients who experienced aspirin resistance with once-daily dosing overcame it when aspirin was administered in 2 daily doses.

A highly anticipated study found that a combination of niacin and the anti-flushing agent laropiprant offers no benefit to patients with vascular disease and may actually harm patients.

In some circumstances, antihypertensives can play a role in treatment even when a patient's blood pressure readings are normal.

Patients may have questions about their uncomfortable leg sensations.

Patients may have questions about their uncomfortable leg sensations.

Almost half of study participants with diabetes had osteoarthritis compared with 26% of participants without diabetes.

A new wave of mobile applications encourages disease management on the go.

Sterility is not maintained by putting a new needle on a used pen device.

Diabetes patients appear to be at significantly increased risk of experiencing proton pump inhibitor (PPI) failure. In addition, PPIs may be an effective means of increasing glycemic control in diabetes patients.